Evidence map›Paper›PMID 25383225›Full record

ArticleInternational journal of medicinal chemistry2014

Clicked cinnamic/caffeic esters and amides as radical scavengers and 5-lipoxygenase inhibitors.

Jérémie A Doiron, Benoît Métayer, Ryan R Richard, Dany Desjardins, Luc H Boudreau, Natalie A Levesque, Jacques Jean-François, Samuel J Poirier, Marc E Surette, Mohamed Touaibia

Open access · hybridAbstract read
In one paragraph

Article in International journal of medicinal chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Jérémie A DoironDépartement de Chimie et Biochimie, Université de Moncton, Moncton, NB, Canada E1A 3E9.
Benoît MétayerDépartement de Chimie et Biochimie, Université de Moncton, Moncton, NB, Canada E1A 3E9.
Ryan R RichardDépartement de Chimie et Biochimie, Université de Moncton, Moncton, NB, Canada E1A 3E9.
Dany DesjardinsDépartement de Chimie et Biochimie, Université de Moncton, Moncton, NB, Canada E1A 3E9.
Luc H BoudreauDépartement de Chimie et Biochimie, Université de Moncton, Moncton, NB, Canada E1A 3E9 ; Centre de Recherche en Rhumatologie et Immunologie et Faculté de Médecine, Université Laval, Québec, QC, Canada G1V 4G2.
Natalie A LevesqueDépartement de Chimie et Biochimie, Université de Moncton, Moncton, NB, Canada E1A 3E9.
Jacques Jean-FrançoisDépartement de Chimie et Biochimie, Université de Moncton, Moncton, NB, Canada E1A 3E9.
Samuel J PoirierDépartement de Chimie et Biochimie, Université de Moncton, Moncton, NB, Canada E1A 3E9.
Marc E SuretteDépartement de Chimie et Biochimie, Université de Moncton, Moncton, NB, Canada E1A 3E9.
Mohamed TouaibiaDépartement de Chimie et Biochimie, Université de Moncton, Moncton, NB, Canada E1A 3E9.
Université de Moncton · CAUniversité Laval · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

5-Lipoxygenase (5-LO) is the key enzyme responsible for the conversion of arachidonic acid to leukotrienes, a class of lipid mediators implicated in inflammatory disorders. In this paper, we describe the design, synthesis, and preliminary activity studies of novel clicked caffeic esters and amides as radical scavengers and 5-LO inhibitors. From known 5-LO inhibitor 3 as a lead, cinnamic esters 8a-h and amides 9a-h as well as caffeic esters 15a-h and amides 16a-h were synthesized by Cu(I)-catalyzed [1,3]-dipolar cycloaddition with the appropriate azide precursors and terminal alkynes. All caffeic analogs are proved to be good radical scavengers (IC50: 10-20 μM). Esters 15g and 15f possessed excellent 5-LO inhibition activity in HEK293 cells and were equipotent with the known 5-LO inhibitor CAPE and more potent than Zileuton. Several synthesized esters possess activities rivaling Zileuton in stimulated human polymorphonuclear leukocytes.

Identifiers

PMID25383225
PMCPMC4207410
OpenAlexW2073517330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.